FDA commissioner-designate
This article was originally published in The Rose Sheet
Executive Summary
Jane Henney, MD, expected to be sworn into office following Nov. 3 general elections. Henney may report to work by the end of November, at the earliest. Linda Suydam, associate commissioner for strategic management, is heading up the transition team until Henney starts. As commissioner, Henney will oversee the final rule on material time/material extent regs for foreign data and OTC sunscreens, the latter due out before June 1, 1999. While her confirmation will inevitably lead to some changes at the top level of FDA, it may not have much impact on center-level management. The ceremony is likely to take place at the White House